IP Library Granted Patent US 10,391,071
Granted Patent B2
US 10,391,071 · App. 15/569,676 · Granted Aug 27, 2019

Compositions comprising valerian extracts

Inventors: Lorenzo Zanella (Venezia-Maestre, IT); Michele Massironi (Padua, IT); Paolo Pertile (San Pietro Viminarlo-Padua, IT)
Assignee: CUTECH SRL
A61K31/19A61K8/36A61K8/97A61K36/84A61P17/08A61Q5/006A61Q5/008A61Q5/02A61Q90/00A61K2800/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,391,071
App. No.
15/569,676
Granted
Aug 27, 2019
Kind
B2
Abstract

Suggested is a pharmaceutical composition comprising valerian extracts or their derivatives that is particularly useful for affecting the sebaceous gland metabolism by exerting a relevant activity as regulator of sebum production (sebogenesis) and the subcutis adipocytes metabolism by regulating adipogenesis.

Claims (13)

1. A method for treating scalp disorders caused by excessive sebogenesis, comprising topically administering on the scalp a composition comprising a valerian extract or an ester obtained from the combination of acid contained in the valerian extract with an aliphatic alcohol, in an amount effective for reducing sebum content, thereby treating the scalp disorders caused by the excessive sebogenesis.

2. The method according to claim 1 , wherein the valerian extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol is administered in an amount of about 0.00004 to about 20% b.w.—calculated on the total composition.

3. A method for treating a subject suffering from disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, comprising administering to the subject a composition comprising a valerian extract or an ester obtained from the combination of acid contained in the valerian extract with an aliphatic alcohol, in an amount effective for treatment of the disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, wherein the valerian extract comprises pentanoic acid and/or valerenic acid, and comprising administering the composition to the subject in an amount effective for the treatment of dandruff.

4. The method according to claim 3 , comprising topically or orally administering the extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol.

5. The method according to claim 3 , wherein the valerian extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol is administered in an amount of about 0.00004 to about 20% b.w.—calculated on the total composition.

6. A method for treating a subject suffering from disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, comprising administering to the subject a composition comprising a valerian extract or an ester obtained from the combination of acid contained in the valerian extract with an aliphatic alcohol, in an amount effective for treatment of the disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, wherein the valerian extract comprises pentanoic acid and/or valerenic acid, and comprising administering the composition to the subject in an amount effective for the treatment of seborrhea.

7. The method according to claim 6 , wherein the valerian extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol is administered in an amount of about 0.00004 to about 20% b.w.—calculated on the total composition.

8. The method according to claim 6 , comprising topically or orally administering the extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol.

9. A method for treating scalp disorders caused by excessive sebogenesis, comprising topically administering on the scalp a composition comprising a valerian extract or an ester obtained from the combination of acid contained in the valerian extract with an aliphatic alcohol, in an amount effective for reducing sebum content, thereby treating the scalp disorders caused by the excessive sebogenesis, wherein the valerian extract comprises pentanoic acid and/or valerenic acid.

10. The method according to claim 9 , wherein the valerian extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol is administered in an amount of about 0.00004 to about 20% b.w.—calculated on the total composition.

11. A method for treating a subject suffering from disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, comprising administering to the subject a composition comprising a valerian extract or an ester obtained from the combination of acid contained in the valerian extract with an aliphatic alcohol, in an amount effective for treatment of the disorder of hair and/or skin caused by excessive sebogenesis and/or sebaceous glands and/or hypodermal fat, wherein the valerian extract comprises pentanoic acid and/or valerenic acid, and comprising administering the composition to the subject in an amount effective for the treatment of cellulite.

12. The method according to claim 11 , wherein the valerian extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol is administered in an amount of about 0.00004 to about 20% b.w.—calculated on the total composition.

13. The method according to claim 11 , comprising topically or orally administering the extract or ester obtained from the combination of the acid contained in the valerian extract with aliphatic alcohol.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: SYMRISE SRL
To: SYMRISE AG
Reel/Frame 052298/0095 →
MERGER AND CHANGE OF NAME Recorded Apr 1, 2020
From: CUTECH SRL; SYMRISE SRL
To: SYMRISE SRL
Reel/Frame 052305/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2017
From: ZANELLA, LORENZO; MASSIRONI, MICHELE; PERTILE, PAOLO
To: CUTECH SRL
Reel/Frame 044511/0737 →
Priority Claims (1)
EP 15165451 · Apr 28, 2015 · regional
Continuity (1)
Related Publication 20180116984A1 · May 3, 2018